Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...
SIGNIFICANT progress has been made in TB diagnostics in the past decade as countries in the African region embrace new ...
BillionToOne saw rapid growth in molecular diagnostics, strong Q3 results, and evolving valuation. Read here for more ...
A research team led by Senior Researcher Chanyong Park, Principal Researcher Dongkyu Lee, and Postdoctoral Researcher Changha ...
Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...
IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...
Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...
MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are ...
One of the most immediate impacts of AI in medical genetics lies in diagnosis, particularly for rare and complex genetic ...
Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy protection, with plans to continue operations as it works out a plan to pay its debts. The company, which ...
UP: BHU researchers develop first molecular classification of oral cancer to guide precision therapy
VARANASI: A landmark Indian study, \"Unveiling Oral Cancer’s Molecular Blueprint: A Novel Classification to Guide Precision ...
Learn more about whether AtriCure, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results